Font Size: a A A
Keyword [No-Reflow]
Result: 61 - 80 | Page: 4 of 10
61. Analysis Of Risk Factors Of Coronary No-reflow/Slow-flow Phenomenon And Vulnerability Of Coronary Atherosclerotic Plaque, And The Predictive Value Of Virtual Histology Intravascular Ultrasound In No-reflow/Slow-flow Phenomenon
62. Influence Of Different Application Ways Of Tirofiban On Myocardial Ischemic Reperfusion And Curative Effect Of Emergency PCI In Patients With STEMI
63. Study On Protective Effect Of Myocardium Reperfusion Using Anisodamine Combined With Nicorandil In Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention
64. Prognostic Effects Of Atorvastatin At Different Dosages On Percutaneous Coronary Intervention Among Patients With Unstable Angina Pectoris
65. The Effect Of GP Inhibitors And α-adrenergic Blocking Agents On The No-reflow Phenomenon During PCI
66. Effect Of Nitroprusside On No-relfow In Interventional Treatment Of Myocardial Infarction
67. The Effects Of Tirmethazine On No-refiow Atfer Acute Myocardial Infarction Reperfusion In Hyperhomocysteinemia Rats
68. Intensive Atorvastatin Therapy Decreases No Reflow In Patients Undergoing Elective PCI Which Is Associated With Decreased CRP And Increased Adiponectin
69. The Effects Of Atorvastatin On Myocardial No Reflow After Ischemia And Reperfusion In Rats
70. The Effects Of Captopril In Hyperhomocysteinemia Rats With No-reflow After Acute Myocardial Infarction Reperfusion
71. Influence Factors Of No-reflow Phenomenon During PCI In ACS
72. Quantitative Evaluation Of The Effects Of Ischemic Ostconditioning On Myocardial Microcirculation With Eal-time Myocardial Contrast Echocardiography
73. Correlation Between Platelet Factors As Well As Hs-CRP And No-reflow In Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
74. The Study Of Protection Effects And Mechanisms Of Amiodarone On Myocardial No-reflow Ischemia/Reperfusion In Rabbits
75. Based On The Theory Of Collaterals Disease After Interventional No Reflow Phenomenon Are Discussed
76. Roles Of Fasudil In Coronary Artery No-Reflow In STEMI Patients Undergoing PCI
77. Role Of DNase Based Therapeutic Strategies In Experimental Myocardial Ischemia/Reperfusion Injury:Evidence For Neutrophil Extracellular Traps Mediated Microcirculation Obstruction
78. The Impacts Of Difflerent Interventional Protocols On Recent Outcomes In No-reflow Patients With STEMI
79. Ischemic Postconditioning Reduces Ischemia Ruperfusion Injury In Patients With Acute Myocardial Infarction
80. The Expression And Significance Of GDF-15in Rat Myocardial Anatomic No-reflow Phenomenon
  <<First  <Prev  Next>  Last>>  Jump to